---
title: Home
description: Expert regulatory affairs consultancy helping pharma and life sciences firms enter UK/EU markets with cost-effective compliance solutions.
---

[Skip to content](https://regvista.co.uk/home#main-content)

![](https://regvista.co.uk/hs-fs/hubfs/Company%20Logo.jpg?width=407&height=87&name=Company%20Logo.jpg)Homepage

- [Home](https://regvista.co.uk/home)
- [Services](https://regvista.co.uk/services?hsLang=en)
- [Blog](https://regvista.co.uk/uk-vs-eu-pharmacovigilance-after-brexit?hsLang=en)
  
    - [UK vs EU Pharmacovigilance After Brexit](https://regvista.co.uk/uk-vs-eu-pharmacovigilance-after-brexit?hsLang=en)
    - [EU Pharmaceutical Legislation Reform](https://regvista.co.uk/eu-pharmaceutical-legislation-reform?hsLang=en)
    - [AI in NHS](https://regvista.co.uk/02-aug-26?hsLang=en)
    - [UK International Reliance Procedure](https://regvista.co.uk/05-jul-26?hsLang=en)
    - [CTIS Timeline Calculator](https://regvista.co.uk/ctis-timelines-without-the-guesswork-introducing-regvistas-ctis-assessment-timeline-dashboard?hsLang=en)

[Get started](mailto:deployment@regvista.co.uk)

- [Home](https://regvista.co.uk/home)
- [Services](https://regvista.co.uk/services?hsLang=en)
- [Blog](https://regvista.co.uk/uk-vs-eu-pharmacovigilance-after-brexit?hsLang=en)
  
    - [UK vs EU Pharmacovigilance After Brexit](https://regvista.co.uk/uk-vs-eu-pharmacovigilance-after-brexit?hsLang=en)
    - [EU Pharmaceutical Legislation Reform](https://regvista.co.uk/eu-pharmaceutical-legislation-reform?hsLang=en)
    - [AI in NHS](https://regvista.co.uk/02-aug-26?hsLang=en)
    - [UK International Reliance Procedure](https://regvista.co.uk/05-jul-26?hsLang=en)
    - [CTIS Timeline Calculator](https://regvista.co.uk/ctis-timelines-without-the-guesswork-introducing-regvistas-ctis-assessment-timeline-dashboard?hsLang=en)

[Get started](mailto:deployment@regvista.co.uk)

# Navigating regulation so your science can move forward

Regvista is a specialist consultancy supporting pharma start-ups, life sciences organisations, and prospective Marketing Authorisation Holders to achieve market entry in the UK and EU — efficiently, compliantly, and on budget. 

[Request a Custom Quote](mailto:deployment@regvista.co.uk)[Discover Our Services](https://regvista.co.uk/services?hsLang=en)

![HD-wallpaper-electrons-orbit-genetics-science-protons-neutrons](https://regvista.co.uk/hs-fs/hubfs/HD-wallpaper-electrons-orbit-genetics-science-protons-neutrons.jpg?width=800&height=600&name=HD-wallpaper-electrons-orbit-genetics-science-protons-neutrons.jpg "HD-wallpaper-electrons-orbit-genetics-science-protons-neutrons")

## End-to-end regulatory expertise

From initial strategy to post-market surveillance, our team handles every stage of the regulatory journey — covering three specialist domains.

Regvista empowers **Biopharma** companies, life sciences organisations, and start-ups to navigate UK/EU regulatory requirements efficiently and cost-effectively. Discover our range of tailored services designed to accelerate your market access and ensure full compliance.

Within **Tech** Domain, we provide Advisory Services on AI integration across drug discovery, clinical trials, manufacturing, and pharmacovigilance; regulatory strategy and compliance for AI/ML tools under EMA, MHRA, and EU AI Act; data governance and validation frameworks to ensure transparency, quality, and patient data protection; and help biopharma organizations adopt AI responsibly and effectively.

Within **IP** Domain, we provide End-to-end regulatory and IP strategy, including AI-enabled tools; patent landscaping, filings, and freedom-to-operate assessments to protect innovations; guidance on data/market exclusivity and lifecycle management in the EU; and regulatory submissions and compliance support to ensure smooth approvals and competitive advantage.

 

## Choose how we work together

### Market Entry Strategy & Authorisation

Our expert consultants guide you through the complex process of entering UK and EU markets, ensuring your products achieve Marketing Authorisation Holder (MAH) status. We customise regulatory pathways, facilitate dossier preparation, and support your submissions for faster approvals.

### Regulatory Compliance Management

Stay compliant and reduce operational risks with our comprehensive compliance management solutions. We handle ongoing regulatory obligations, pharmacovigilance, and post-market surveillance, helping you manage costs while maintaining the highest standards.

### Customised Consultancy & Cost Optimisation

Benefit from bespoke consultancy tailored for your business needs. We support start-ups and growing companies with budget-friendly, scalable solutions—helping you optimise regulatory spend without compromising on quality or compliance.

## Starter Consultancy

Ideal for start-ups and emerging businesses entering the pharmaceutical and life sciences sectors in the UK/EU. This plan is perfect for those seeking essential regulatory guidance with a clear, manageable budget.

Pricing per hour

### What's Included

- Initial regulatory assessment
- Tailored compliance roadmap
- Access to regulatory updates
- One revision of documentation

[Request a Quote](https://regvista.co.uk/home#contact)

## Growth MAH Support

Designed for prospective Marketing Authorisation Holders (MAH) looking to expand market access efficiently. Benefit from comprehensive support to manage ongoing compliance and facilitate UK/EU market penetration.

Pricing per project/month

### Features

- Ongoing regulatory support
- Dossier preparation and review
- Submission management
- MHRA/EMA liaison
- Quarterly training sessions

[Contact for Custom Plan](https://regvista.co.uk/home#contact)

## Full Suite Enterprise

Tailored for established pharmaceutical and life sciences organisations requiring a complete regulatory affairs solution. This plan offers end-to-end support for complex projects and robust compliance management.

Custom Pricingper engagement

### Plan Includes

- Dedicated regulatory affairs manager
- Full project lifecycle management
- Comprehensive compliance audits
- Bespoke regulatory strategy development
- Priority support & updates

[Schedule a Consultation](https://regvista.co.uk/home#contact)

## Your trusted UK/EU regulatory partner

**Post-Brexit dual access**

Our UK base gives us unique positioning to act as your UK partner while facilitating EU submissions — a strategic advantage in the post-Brexit landscape.

 

**Joined-up expertise**

Rare combination of biopharma, AI/digital health, and IP regulatory expertise under one roof — no need to manage multiple specialist advisors.

 

**Built for start-ups**

We understand the budget pressures of early-stage companies and design our engagements to be scalable, flexible, and cost-effective from day one.

 

**Every step covered**

From initial regulatory strategy and dossier prep through to post-market surveillance and ongoing compliance — we're with you for the full journey.

- ![images (1)](https://regvista.co.uk/hs-fs/hubfs/images%20(1).jpg?width=192&height=125&name=images%20(1).jpg)
- ![image](https://regvista.co.uk/hs-fs/hubfs/AI-Generated%20Media/Images/image.jpeg?width=1344&height=768&name=image.jpeg)
- ![ip-infringement](https://regvista.co.uk/hs-fs/hubfs/ip-infringement.png?width=1300&height=835&name=ip-infringement.png)
- ![0446c9\_9430913e750d48a8bb395e316c8843de~mv2](https://regvista.co.uk/hs-fs/hubfs/0446c9_9430913e750d48a8bb395e316c8843de~mv2.png?width=568&height=320&name=0446c9_9430913e750d48a8bb395e316c8843de~mv2.png)

![9d17518b-7a96-4901-afa1-cd0a0103d7a1-1](https://regvista.co.uk/hs-fs/hubfs/9d17518b-7a96-4901-afa1-cd0a0103d7a1-1.png?width=1536&height=1024&name=9d17518b-7a96-4901-afa1-cd0a0103d7a1-1.png "9d17518b-7a96-4901-afa1-cd0a0103d7a1-1")

## Your partner in Bio-Pharma Regulatory Affairs Services

**Ready to accelerate your market access?**

 

Tell us about your project and we'll outline a tailored regulatory pathway.

 

## Our Services

Please visit our [services](https://regvista.co.uk/services?hsLang=en) section for more details on service offerings across various sectors. 

### Business Enquiry

- [Home](https://regvista.co.uk/home)
- [Services](https://regvista.co.uk/services?hsLang=en)
- [Blog](https://regvista.co.uk/uk-vs-eu-pharmacovigilance-after-brexit?hsLang=en)

<https://www.linkedin.com><https://www.facebook.com><https://www.twitter.com><https://www.instagram.com><https://www.tiktok.com>

---

Privacy Policy · Legal · © 2026 Regvista. All rights reserved.